BioCentury
ARTICLE | Clinical News

Relistor methylnaltrexone regulatory update

June 15, 2015 7:00 AM UTC

The European Commission approved an expanded label for subcutaneous Relistor methylnaltrexone from Valeant and Progenics to treat opioid-induced constipation (OIC) in adults when response to laxative ...